4:23 PM
Apr 13, 2018
 |  BC Extra  |  Preclinical News

Autophagy enhancers as metabolic syndrome therapy

In a study published in Nature Communications, a team of South Korean researchers identified small molecule autophagy enhancers that could help treat metabolic syndromes.

Autophagy -- a lysomome-mediated degradation pathway -- is an increasingly popular target for drug developers looking to treat multiple diseases due to its role as a regulator of cellular homeostasis. While autophagy inhibition has shown...

Read the full 279 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >